Log in to save to my catalogue

Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐li...

Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐li...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7780027

Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy

About this item

Full title

Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2021-01, Vol.112 (1), p.359-368

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Despite the importance of accurate disease definitions for effective management and treatment decisions, there is currently no consensus on what constitutes oligometastatic non–small‐cell lung cancer (NSCLC). Predominant patterns of initial progressive disease (PD) after first‐line systemic therapy have been shown to be a substantial basis for loca...

Alternative Titles

Full title

Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7780027

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7780027

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.14707

How to access this item